Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Resource Type
Article
Authors
Cavo, Michele ; Gay, Francesca ; Beksac, Meral ; Pantani, Lucia ; Petrucci, Maria Teresa ; Dimopoulos, Meletios A ; Dozza, Luca ; van der Holt, Bronno ; Zweegman, Sonja ; Oliva, Stefania ; van der Velden, Vincent H J ; Zamagni, Elena ; Palumbo, Giuseppe A ; Patriarca, Francesca ; Montefusco, Vittorio ; Galli, Monica ; Maisnar, Vladimir ; Gamberi, Barbara ; Hansson, Markus ; Belotti, Angelo ; Pour, Ludek ; Ypma, Paula ; Grasso, Mariella ; Croockewit, Alexsandra ; Ballanti, Stelvio ; Offidani, Massimo ; Vincelli, Iolanda D ; Zambello, Renato ; Liberati, Anna Marina ; Andersen, Niels Frost ; Broijl, Annemiek ; Troia, Rossella ; Pascarella, Anna ; Benevolo, Giulia ; Levin, Mark-David ; Bos, Gerard ; Ludwig, Heinz ; Aquino, Sara ; Morelli, Anna Maria ; Wu, Ka Lung ; Boersma, Rinske ; Hajek, Roman ; Durian, Marc ; von dem Borne, Peter A ; Caravita di Toritto, Tommaso ; Zander, Thilo ; Driessen, Christoph ; Specchia, Giorgina ; Waage, Anders ; Gimsing, Peter ; Mellqvist, Ulf-Henrik ; van Marwijk Kooy, Marinus ; Minnema, Monique ; Mandigers, Caroline ; Cafro, Anna Maria ; Palmas, Angelo ; Carvalho, Susanna ; Spencer, Andrew ; Boccadoro, Mario ; Sonneveld, Pieter
Source
In The Lancet Haematology June 2020 7(6):e456-e468
Subject
Primary Research Articles
Language
ISSN
2352-3026